These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18797412)

  • 1. Fibrogenic polymorphisms (TGF-beta, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential correlation with pirfenidone treatment.
    Armendáriz-Borunda J; Rincón AR; Muñoz-Valle JF; Bueno-Topete M; Oregón-Romero E; Islas-Carbajal MC; Medina-Preciado D; González-García I; Bautista CA; García-Rocha S; Godoy J; Vázquez-Del Mercado M; Troyo-SanRoman R; Arellano-Olivera I; Lucano S; Alvarez-Rodríguez A; Salazar A
    J Investig Med; 2008 Oct; 56(7):944-53. PubMed ID: 18797412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
    Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP
    Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genetic polymorphisms with histological grading of necroinflammation, staging of fibrosis, and liver function in Mexicans with chronic hepatitis C virus infection.
    Sánchez-Parada MG; Alvarez-Rodríguez BA; Gómez-Meda BC; Troyo-Sanromán R; Sánchez-Orozco LV; Zamora-Perez AL; Landeros MS; Armendáriz-Borunda J
    J Investig Med; 2013 Oct; 61(7):1088-96. PubMed ID: 23941979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer.
    Smolarz B; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B; Szewczyk T
    J Exp Clin Cancer Res; 2001 Jun; 20(2):247-52. PubMed ID: 11484982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Synergistic Effect of TNFα -308 G/A and TGFβ1 -509 C/T Polymorphisms on Hepatic Fibrosis Progression in Hepatitis C Virus Genotype 4 Patients.
    Bader El Din NG; Farouk S; El-Shenawy R; Elhady MM; Ibrahim MK; Dawood RM; Salem AM; El Awady MK
    Viral Immunol; 2017 Mar; 30(2):127-135. PubMed ID: 28151059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis.
    Gewaltig J; Mangasser-Stephan K; Gartung C; Biesterfeld S; Gressner AM
    Clin Chim Acta; 2002 Feb; 316(1-2):83-94. PubMed ID: 11750277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled clinical trial with pirfenidone in the treatment of breast capsular contracture: association of TGF-β polymorphisms.
    Veras-Castillo ER; Cardenas-Camarena L; Lyra-Gonzalez I; Muñoz-Valle JF; Lucano-Landeros S; Guerrerosantos J; Gonzalez-Ulloa B; Mercado-Barajas JL; Sanchez-Parada MG; Azabache-Wennceslao R; Armendariz-Borunda J
    Ann Plast Surg; 2013 Jan; 70(1):16-22. PubMed ID: 21712700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic pulmonary fibrosis in relation to gene polymorphisms of transforming growth factor-β1 and plasminogen activator inhibitor 1.
    Li XX; Li N; Ban CJ; Zhu M; Xiao B; Dai HP
    Chin Med J (Engl); 2011 Jul; 124(13):1923-7. PubMed ID: 22088447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host genetic factors influence disease progression in chronic hepatitis C.
    Powell EE; Edwards-Smith CJ; Hay JL; Clouston AD; Crawford DH; Shorthouse C; Purdie DM; Jonsson JR
    Hepatology; 2000 Apr; 31(4):828-33. PubMed ID: 10733535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A; Emingil G; Saygan BH; Cinarcik S; Atilla G; Köse T; Berdeli A
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection.
    Suzuki S; Tanaka Y; Orito E; Sugauchi F; Hasegawa I; Sakurai M; Fujiwara K; Ohno T; Ueda R; Mizokami M
    J Gastroenterol Hepatol; 2003 Oct; 18(10):1139-43. PubMed ID: 12974899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
    J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L; Jin H; Song K; Zhang C; Shen J; Huang Y
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of polymorphic markers for the genes of hemostasis and platelet receptors in liver fibrosis progression in patients with chronic hepatitis C].
    Starostina EE; Samokhodskaya LM; Rozina TP; Krasnova TN; Yarovaya EB; Mukhin NA
    Ter Arkh; 2016; 88(8):93-98. PubMed ID: 27636933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of --844 G/A and Hind III C/G PAI-1 polymorphisms and plasma PAI-1 levels in Mexican subjects: comparison of frequencies between populations.
    Torres-Carrillo N; Magdalena Torres-Carrillo N; Vázquez-Del Mercado M; Rangel-Villalobos H; Parra-Rojas I; Sánchez-Enríquez S; Muñoz-Valle JF
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):220-6. PubMed ID: 18263635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy.
    Chen CH; Shu KH; Wen MC; Chen KJ; Cheng CH; Lian JD; Wu MJ; Yu TM; Tsai FJ
    Nephrol Dial Transplant; 2008 Oct; 23(10):3166-73. PubMed ID: 18495745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.
    Sogutlu Sari E; Yazici A; Eser B; Erol MK; Kilic A; Ermis SS; Koytak A; Akşit H; Yakut T
    Cutan Ocul Toxicol; 2014 Dec; 33(4):270-4. PubMed ID: 24446892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.